Evaluation of inflammatory markers obtained from complete blood count in different stages of schizophrenia

• Published in: Current medical research and opinion 2024-08, Vol.40 (8), p.1413-1419
• Main Authors: Bilgin Koçak, Merve, Öztürk Atkaya, Neşe, Oruç, Muhammet Ali
• Format: Article
• Language: English
• Subjects: Adult; Biomarkers - blood; Blood Cell Count; Blood Platelets - pathology; Case-Control Studies; Female; Humans; Inflammation - blood; Lymphocytes; Male; Middle Aged; Monocytes; Neutrophils; Schizophrenia - blood
• ISSN: 0300-7995; 1473-4877; 1473-4877
• DOI: 10.1080/03007995.2024.2378180

Systemic inflammatory biomarkers recently studied in schizophrenia include neutrophil/lymphocyte ratio (NLR), monocyte/lymphocyte ratio (MLR), platelet/lymphocyte ratio (PLR), systemic immune inflammation index (SII), and systemic inflammation response index (SIRI). SIRI, a novel inflammatory marker, has not been studied in different stages of schizophrenia. We aimed to compare NLR, MLR, PLR, SII, and SIRI values between psychotic exacerbation and remission values of the same patients with schizophrenia and a healthy control group. In this study, 86 patients with schizophrenia who were hospitalized due to psychotic relapse, the same patient group who were in remission after treatment, and 86 age-sex-matched healthy control subjects were analyzed. Inflammatory marker values of the patient group in both the psychotic exacerbation (PE) and the remission (R) period were analyzed and compared with healthy controls (HC). NLR, MLR, PLR, SII, and SIRI values were significantly higher in the schizophrenia-PE group than in the HC group. NLR, MLR, SII, and SIRI values were significantly higher in the schizophrenia-PE group than in the schizophrenia-R group. MLR values were significantly higher in the schizophrenia-R group than in the HC group. These findings may be interpreted as NLR, SII, and SIRI, which may be considered as state biomarkers, and MLR may be a trait marker for schizophrenia.